Valuation: EMVision Medical Devices Ltd

Market Cap 157M 112M 96.83M 91.37M 82.9M 156M 10.71B 1.09B 421M 5.43B 420M 410M 17.27B P/E 2027 *
-14.9x
P/E 2028 * -13x
Enterprise Value 157M 112M 96.83M 91.37M 82.9M 156M 10.71B 1.09B 421M 5.43B 420M 410M 17.27B EV / Sales 2027 *
31.3x
EV / Sales 2028 * 18.4x
Free-Float
66.77%
Yield 2027 *
-
Yield 2028 * -
1 day-3.44%
1 week-10.37%
Current month-1.46%
1 month-2.60%
3 months+7.32%
6 months+6.65%
Current year-5.34%
1 week 1.67
Extreme 1.67
1.87
1 month 1.64
Extreme 1.635
1.9
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.36
3 years 1.44
Extreme 1.445
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap. Importance
4/23/26 A Buy

Director

10,000 0.0108%
1/2/26 A Expiration

Chairman

300,000 0.3228%
11/18/25 A Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-3.44%-10.37%-27.37%+6.65% 116M
+0.62%+1.76%+29.33%+19.00% 225B
+1.55%-0.96%+7.80%-19.82% 141B
+2.38%+7.93%-12.92%+24.43% 130B
+4.82%+0.16%-54.89%-14.87% 62.29B
+1.99%-0.03%-18.12%-12.87% 49.39B
+1.36%-1.38%+12.45%+15.54% 48.63B
-0.09%-0.03%+16.85%+27.79% 41.42B
+0.41%+1.76%+37.11%+50.73% 40.12B
+2.16%+0.88%-17.77%+51.04% 31.23B
Average +1.10%-3.62%-2.75%+14.76% 76.98B
Weighted average by Cap. +1.52%-2.40%+5.13%+11.25%

Financials

2027 *2028 *
Net sales 5M 3.57M 3.09M 2.92M 2.65M 4.96M 342M 34.84M 13.42M 173M 13.4M 13.1M 551M 8.5M 6.06M 5.25M 4.96M 4.5M 8.44M 581M 59.22M 22.82M 295M 22.78M 22.27M 937M
Net income -12M -8.56M -7.42M -7M -6.35M -11.91M -821M -83.61M -32.22M -416M -32.15M -31.45M -1.32B -14.5M -10.34M -8.96M -8.46M -7.67M -14.4M -991M -101M -38.93M -503M -38.85M -38M -1.6B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
14/09/26 A$1.685 -3.44% 8,835
11/09/26 A$1.745 0.00% 5,920
10/09/26 A$1.745 -3.06% 31,177
09/09/26 A$1.800 -2.17% 39,954
08/09/26 A$1.840 -2.13% 19,173
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.685AUD
Average target price
3.150AUD
Spread / Average Target
+86.94%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!